Showing results (1-10 of 58) with videos related to
Sort By:
Pageof 6
Cancer Cell|January 18, 2006
p63 and p73: teammates or adversaries?Edward Ratovitski, Barry Trink, David SidranskyInternational Journal of Cancer|February 26, 2011
BRAF mutation-selective inhibition of thyroid cancer cells by the novel MEK inhibitor RDEA119 and genetic-potentiated synergism with the mTOR inhibitor temsirolimusDingxie Liu, Joanna Xing, Barry Trink, et al.Biochemical and Biophysical Research Communications|December 28, 2010
The BRAFT1799A mutation confers sensitivity of thyroid cancer cells to the BRAFV600E inhibitor PLX4032 (RG7204)Joanna Xing, Ruixin Liu, Mingzhao Xing, et al.Cell Cycle (Georgetown, Tex.)|February 14, 2007
p63 transcriptional regulation of epithelial integrity and cancerBarry Trink, Motonobu Osada, Edward Ratovitski, et al.Trends in Biotechnology|July 31, 2017
Plasmas for Treating Cancer: Opportunities for Adaptive and Self-Adaptive ApproachesMichael Keidar, Dayun Yan, Isak I Beilis, et al.Biochemical and Biophysical Research Communications|April 3, 2007
TAp63gamma regulates hOGG1 and repair of oxidative damage in cancer cell linesSunil Upadhyay, Aditi Chatterjee, Barry Trink, et al.Cell Cycle (Georgetown, Tex.)|April 18, 2008
U-box-type ubiquitin E4 ligase, UFD2a attenuates cisplatin mediated degradation of DeltaNp63alphaAditi Chatterjee, Sunil Upadhyay, Xiaofei Chang, et al.Cell Cycle (Georgetown, Tex.)|May 13, 2008
Midkine induces epithelial-mesenchymal transition through Notch2/Jak2-Stat3 signaling in human keratinocytesYiping Huang, Mohammad Obaidul Hoque, Feng Wu, et al.Oncogene|October 10, 2003
Biallelic inactivation of the RIZ1 gene in human gastric cancerYutaka Tokumaru, Shuji Nomoto, Carmen Jerónimo, et al.Cell Cycle (Georgetown, Tex.)|September 5, 2008
ATM kinase is a master switch for the Delta Np63 alpha phosphorylation/degradation in human head and neck squamous cell carcinoma cells upon DNA damageYiping Huang, Tanusree Sen, Jatin Nagpal, et al.Pageof 6